Provided by Tiger Fintech (Singapore) Pte. Ltd.

Serina Therapeutics, Inc.

5.85
-0.2400-3.94%
Volume:10.89K
Turnover:62.37K
Market Cap:58.10M
PE:-3.86
High:6.03
Open:6.03
Low:5.44
Close:6.09
Loading ...
Apr 03, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Feb 14, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Correspondence

Form CORRESP - Correspondence
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Jan 19, 2024

Major Issues Report

Form 8-K - Current report
Jan 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 11, 2024

Major Issues Report

Form 8-K - Current report
Jan 09, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 28, 2023

Major Issues Report

Form 8-K - Current report